160 related articles for article (PubMed ID: 7628208)
1. Acrosin inhibitor, 4'-acetamidophenyl 4-guanidinobenzoate, an experimental vaginal contraceptive with anti-HIV activity.
Bourinbaiar AS; Lee-Huang S
Contraception; 1995 May; 51(5):319-22. PubMed ID: 7628208
[TBL] [Abstract][Full Text] [Related]
2. Development of the polyurethane sponge as a delivery system for aryl 4-guanidinobenzoates.
Quigg JM; Miller IF; Mack SR; Saxena SJ; Kaminski JM; Zaneveld LJ
Contraception; 1988 Oct; 38(4):487-97. PubMed ID: 2850136
[TBL] [Abstract][Full Text] [Related]
3. Vaginal contraceptive activity of aryl 4-guanidinobenzoates (acrosin inhibitors) in rabbits.
Kaminski JM; Nuzzo NA; Bauer L; Waller DP; Zaneveld LJ
Contraception; 1985 Aug; 32(2):183-9. PubMed ID: 3000689
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol.
Bourinbaiar AS; Lee-Huang S
Contraception; 1994 Feb; 49(2):131-7. PubMed ID: 7511493
[TBL] [Abstract][Full Text] [Related]
5. Effect of aryl 4-guanidinobenzoates on the acrosin activity of human spermatozoa.
Kaminski JM; Smith D; Reid DS; Kennedy W; Jeyendran RS; Zaneveld LJ
Biol Reprod; 1987 Jun; 36(5):1170-6. PubMed ID: 3304435
[TBL] [Abstract][Full Text] [Related]
6. WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity.
D'Cruz OJ; Zhu Z; Yiv SH; Chen CL; Waurzyniak B; Uckun FM
Contraception; 1999 May; 59(5):319-31. PubMed ID: 10494486
[TBL] [Abstract][Full Text] [Related]
7. Comparative spermicidal performance of iodinated and non-iodinated contraceptive formulations of nonoxynol-9 co-precipitated with polyvinylpyrrolidone.
Zavos PM; Correa JR; Nosek D; Mohammadi F; Digenis GA
Contraception; 1996 Jul; 54(1):39-41. PubMed ID: 8804807
[TBL] [Abstract][Full Text] [Related]
8. Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate.
Psychoyos A; Creatsas G; Hassan E; Georgoulias V; Gravanis A
Hum Reprod; 1993 Jun; 8(6):866-9. PubMed ID: 7688380
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and inhibition of human acrosin and trypsin and acute toxicity of aryl 4-guanidinobenzoates.
Kaminski JM; Bauer L; Mack SR; Anderson RA; Waller DP; Zaneveld LJ
J Med Chem; 1986 Apr; 29(4):514-9. PubMed ID: 3514912
[TBL] [Abstract][Full Text] [Related]
10. Zinc acetate and lyophilized aloe barbadensis as vaginal contraceptive.
Fahim MS; Wang M
Contraception; 1996 Apr; 53(4):231-6. PubMed ID: 8706441
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in-vitro.
Jennings R; Clegg A
J Antimicrob Chemother; 1993 Jul; 32(1):71-82. PubMed ID: 7693643
[TBL] [Abstract][Full Text] [Related]
12. Physiological aspects of vaginal contraception.
Bernstein GS
Contraception; 1974 Apr; 9(4):333-45. PubMed ID: 4613535
[TBL] [Abstract][Full Text] [Related]
13. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
14. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
15. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
[TBL] [Abstract][Full Text] [Related]
16. Discovery of substituted isoxazolecarbaldehydes as potent spermicides, acrosin inhibitors and mild anti-fungal agents.
Gupta G; Jain RK; Maikhuri JP; Shukla PK; Kumar M; Roy AK; Patra A; Singh V; Batra S
Hum Reprod; 2005 Aug; 20(8):2301-8. PubMed ID: 15932909
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9.
Mauck CK; Allen S; Baker JM; Barr SP; Abercrombie T; Archer DF
Contraception; 1997 Aug; 56(2):103-10. PubMed ID: 9315419
[TBL] [Abstract][Full Text] [Related]
18. Dose-response effects of gramicidin-D, EDTA, and nonoxynol-9 on sperm motion parameters and acrosome status.
Centola GM
Contraception; 1998 Jul; 58(1):35-8. PubMed ID: 9743894
[TBL] [Abstract][Full Text] [Related]
19. The influence of nonoxynol-9-containing spermicides on urogenital infection.
McGroarty JA; Reid G; Bruce AW
J Urol; 1994 Sep; 152(3):831-3. PubMed ID: 8051730
[TBL] [Abstract][Full Text] [Related]
20. Sperm enzyme inhibitors for vaginal and other contraception.
Zaneveld LJ
Res Front Fertil Regul; 1982 Dec; 2(3):1-14. PubMed ID: 12179623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
